CSMF
GILD icon

Charles Stewart Mott Foundation’s Gilead Sciences GILD Stock Holding History

Charles Stewart Mott Foundation’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,151
Closed -$604K – 35
2015
Q3 		$604K Buy
+6,151
New +$683K 0.68% 23

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Stewart Mott Foundation's GILD Position: Q4 2015 in Review

Charles Stewart Mott Foundation sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 6,151 shares — an estimated $604K sold.

Charles Stewart Mott Foundation first reported a position in GILD in Q3 2015 and held it in 1 quarter. The position peaked at $604K in Q3 2015. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Charles Stewart Mott Foundation reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Charles Stewart Mott Foundation sold 6,151 Gilead Sciences shares in Q4 2015, an estimated $604K.
  • Charles Stewart Mott Foundation first reported a position in Gilead Sciences in Q3 2015 and held it in 1 quarter.
  • Charles Stewart Mott Foundation's Gilead Sciences position peaked at $604K in Q3 2015.
  • 1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Charles Stewart Mott Foundation's 13F filing for Q4 2015, filed 16 Feb 2016.